Terms: = Thyroid cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Treatment
144 results:
1. Second radioiodine treatment in patients with differentiated thyroid carcinoma: Causes and effects.
Sicilia Pozo MLN; Pena Pardo FJ; Amo Salas M; Cruz Montijano M; Torres Hernández J; Padilla Bermejo A; Montalbán Méndez C; Zhao Montero M; Soriano Castrejón Á; García Vicente AM
Endocrinol Diabetes Nutr (Engl Ed); 2024 Jan; 71(1):4-11. PubMed ID: 38388076
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients.
Zheng X; Fang M; Fan Y; Sun Y; Sun M; Yang A; Zhang B; Liu Q; Liu H; Zhou X; Huang T; Qin J; Wang Z; Qin M; Shen Z; Yao S; Yang J; Wang Y; Gao M
Endocr Relat Cancer; 2024 Apr; 31(4):. PubMed ID: 38261313
[TBL] [Abstract] [Full Text] [Related]
3. Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered thyroid cancer: Updated Efficacy and Safety Data from the ARROW Study.
Subbiah V; Hu MI; Mansfield AS; Taylor MH; Schuler M; Zhu VW; Hadoux J; Curigliano G; Wirth L; Gainor JF; Alonso G; Adkins D; Godbert Y; Ahn MJ; Cassier PA; Cho BC; Lin CC; Zalutskaya A; Barata T; Trask P; Scalori A; Bordogna W; Heinzmann S; Brose MS
Thyroid; 2024 Jan; 34(1):26-40. PubMed ID: 38009200
[No Abstract] [Full Text] [Related]
4. Age-stratified comparison of active surveillance versus radiofrequency ablation for papillary thyroid microcarcinoma using decision analysis.
Carlisle KM; Brown JP; Kim J; Turner DJ; Slejko JF; Kuo JH; Mullins CD; Hu Y
Surgery; 2024 Jan; 175(1):153-160. PubMed ID: 37872047
[TBL] [Abstract] [Full Text] [Related]
5. Effects of Ultrasound-Guided Laser Ablation Therapy on Symptomatic Benign thyroid Nodules, Using EchoLaser - Results of a Pilot Study in the United States.
Thomas J; Ledger GA; Haertling T
Endocr Pract; 2023 Dec; 29(12):942-947. PubMed ID: 37704167
[TBL] [Abstract] [Full Text] [Related]
6. Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study.
Bersanelli M; Cortellini A; Leonetti A; Parisi A; Tiseo M; Bordi P; Michiara M; Bui S; Cosenza A; Ferri L; Giudice GC; Testi I; Rapacchi E; Camisa R; Vincenzi B; Caruso G; Rauti AN; Arturi F; Tucci M; Santo V; Ricozzi V; Burtet V; Sgargi P; Todeschini R; Zustovich F; Stucci LS; Santini D; Buti S
Cancer Immunol Immunother; 2023 Nov; 72(11):3707-3716. PubMed ID: 37638980
[TBL] [Abstract] [Full Text] [Related]
7. Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial.
Sherman EJ; Harris J; Bible KC; Xia P; Ghossein RA; Chung CH; Riaz N; Gunn GB; Foote RL; Yom SS; Wong SJ; Koyfman SA; Dzeda MF; Clump DA; Khan SA; Shah MH; Redmond K; Torres-Saavedra PA; Le QT; Lee NY
Lancet Oncol; 2023 Feb; 24(2):175-186. PubMed ID: 36681089
[TBL] [Abstract] [Full Text] [Related]
8. Models of ultrasonic radiomics and clinical characters for lymph node metastasis assessment in thyroid cancer: a retrospective study.
Zhu H; Yu B; Li Y; Zhang Y; Jin J; Ai Y; Jin X; Yang Y
PeerJ; 2023; 11():e14546. PubMed ID: 36650830
[TBL] [Abstract] [Full Text] [Related]
9. DOSE RELATIONSHIP DURING RADIOABLATION OF thyroid RESIDUAL IN PATIENTS WITH thyroid DIFFERENTIATED cancer.
Dzhuzha DO
Probl Radiac Med Radiobiol; 2022 Dec; 27():431-439. PubMed ID: 36582107
[TBL] [Abstract] [Full Text] [Related]
10. Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial.
Wu J; Jiang Z; Liu Z; Yang B; Yang H; Tang J; Wang K; Liu Y; Wang H; Fu P; Zhang S; Liu Q; Wang S; Huang J; Wang C; Wang S; Wang Y; Zhen L; Zhu X; Wu F; Lin X; Zou J
BMC Med; 2022 Dec; 20(1):498. PubMed ID: 36575513
[TBL] [Abstract] [Full Text] [Related]
11. [Association of extranodal extension and lymph node ratio with radioactive iodine-refractory papillary thyroid cancer].
Luo ZY; Qin JW; Fang JG; Zheng C; Gong WB; Hei H
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3856-3861. PubMed ID: 36540923
[No Abstract] [Full Text] [Related]
12. Breast cancer risk among thyroid cancer survivors and the role of I-131 treatment.
Tran TV; Rubino C; Allodji R; Andruccioli M; Bardet S; Diallo I; Dottorini M; Garsi J; Hall P; Henry-Amar M; Lamart S; Le Thai F; Lönn S; Ricard M; Schvartz C; Schlumberger M; Journy N; de Vathaire F
Br J Cancer; 2022 Dec; 127(12):2118-2124. PubMed ID: 36224404
[TBL] [Abstract] [Full Text] [Related]
13. Risk Factors for Pulmonary Metastasis in Differentiated thyroid Carcinoma Patients and the Significance of Changes in Matrix Metalloproteinase 13 and microRNA-142 Levels.
Zhang X; Lu Z; Zhang G; Li S; Zhao A; Miao Y; Wang W
Contrast Media Mol Imaging; 2022; 2022():6820281. PubMed ID: 36118948
[TBL] [Abstract] [Full Text] [Related]
14. Establishment and validation of a LC-MS/MS method for the determination of anlotinib in human plasma: Application to therapeutic drug monitoring.
Yu M; Liang Z; Xiong L; Liu F; Cheng L; Jia C; Qi X; Sun F
Biomed Chromatogr; 2022 Dec; 36(12):e5501. PubMed ID: 36082703
[TBL] [Abstract] [Full Text] [Related]
15. Feasibility of therapeutic drug monitoring of sorafenib in patients with liver or thyroid cancer.
Guchelaar NAD; van Eerden RAG; Groenland SL; Doorn LV; Desar IME; Eskens FALM; Steeghs N; van Erp NP; Huitema ADR; Mathijssen RHJ; Koolen SLW;
Biomed Pharmacother; 2022 Sep; 153():113393. PubMed ID: 35834987
[TBL] [Abstract] [Full Text] [Related]
16. The Effect of Laser Thermal Ablation on Quality of Life: Improvements in Patients with Solid-Cystic thyroid Nodules.
Sorensen JR; Døssing H; Watt T; Cramon P; Hegedüs L; Bonnema SJ; Folkestad L
Thyroid; 2022 Aug; 32(8):917-925. PubMed ID: 35570722
[No Abstract] [Full Text] [Related]
17. A real-world study on the safety of the extended dosing schedule for nivolumab and pembrolizumab in patients with solid tumors.
Morimoto K; Yamada T; Morimoto Y; Ishikawa T; Asai J; Fujihara A; Arai A; Katoh N; Ukimura O; Hirano S; Itoh Y; Takayama K
Int Immunopharmacol; 2022 Jul; 108():108775. PubMed ID: 35436741
[TBL] [Abstract] [Full Text] [Related]
18. Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intolerance.
Jojima T; Shinzawa T; Ohira E; Sakurai S; Tomaru T; Iijima T; Kogai T; Usui I; Aso Y
Endocr J; 2022 Aug; 69(8):941-945. PubMed ID: 35249899
[TBL] [Abstract] [Full Text] [Related]
19. Effect of S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Plus Oxaliplatin as Perioperative Chemotherapy for Locally Advanced, Resectable Gastric cancer: A Randomized Clinical Trial.
Yu J; Gao Y; Chen L; Wu D; Shen Q; Zhao Z; Liu W; Yang H; Zhang Q; Wang X; Hu P; Zheng Z; Wang X; Liu H; Xu Z; Yan Z; Wu Y; Jin M; Zhang Q; Liu X; Zhu K; Shou C
JAMA Netw Open; 2022 Feb; 5(2):e220426. PubMed ID: 35226081
[TBL] [Abstract] [Full Text] [Related]
20. Joint Detection of Tap and CEA Based on Deep Learning Medical Image Segmentation: Risk Prediction of thyroid cancer.
Lang S; Xu Y; Li L; Wang B; Yang Y; Xue Y; Shi K
J Healthc Eng; 2021; 2021():5920035. PubMed ID: 34158913
[TBL] [Abstract] [Full Text] [Related]
[Next]
